title: Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.
authors.affiliation: Masonic Medical Research Laboratory, Utica, N.Y. 13504.
authors.forename: C
authors.initials: C
authors.lastname: Antzelevitch
authors.forename: S
authors.initials: S
authors.lastname: Sicouri
authors.forename: S H
authors.initials: SH
authors.lastname: Litovsky
authors.forename: A
authors.initials: A
authors.lastname: Lukas
authors.forename: S C
authors.initials: SC
authors.lastname: Krishnan
authors.forename: J M
authors.initials: JM
authors.lastname: Di Diego
authors.forename: G A
authors.initials: GA
authors.lastname: Gintant
authors.forename: D W
authors.initials: DW
authors.lastname: Liu
mesh_terms: D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials; D000367:Age Factors; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015220:Calcium Channels / Q000502:physiology; D003327:Coronary Disease / Q000503:physiopathology; D004285:Dogs; D004553:Electric Conductivity; D004699:Endocardium / Q000502:physiology; D005424:Flecainide / Q000494:pharmacology; D006352:Heart Ventricles / Q000166:cytology; D006358:Hot Temperature; D006801:Humans; D066298:In Vitro Techniques; D010277:Parasympathomimetics / Q000494:pharmacology; D015222:Sodium Channels / Q000502:physiology; D013566:Sympathomimetics / Q000494:pharmacology; D016276:Ventricular Function
chemical_list: D002121:Calcium Channel Blockers; D015220:Calcium Channels; D010277:Parasympathomimetics; D015222:Sodium Channels; D013566:Sympathomimetics; D002110:Caffeine; D000584:Amiloride; D015761:4-Aminopyridine; D005424:Flecainide; D002118:Calcium